Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Institute for Innovation, Ajinomoto Co., Inc., Kawasaki, Japan.
Metabolism. 2014 Feb;63(2):283-95. doi: 10.1016/j.metabol.2013.10.009. Epub 2013 Oct 24.
Hepatic lipotoxicity is characterized by reactive oxygen species (ROS) accumulation, mitochondrial dysfunction, and excessive apoptosis, but the precise sequence of biochemical events leading to oxidative damage and cell death remains unclear. The goal of this study was to delineate the role of mitochondrial metabolism in mediating hepatocyte lipotoxicity.
MATERIALS/METHODS: We treated H4IIEC3 rat hepatoma cells with free fatty acids in combination with antioxidants and mitochondrial inhibitors designed to block key events in the progression toward apoptosis. We then applied (13)C metabolic flux analysis (MFA) to quantify mitochondrial pathway alterations associated with these treatments.
Treatment with palmitate alone led to a doubling in oxygen uptake rate and in most mitochondrial fluxes. Supplementing culture media with the antioxidant N-acetyl-cysteine (NAC) reduced ROS accumulation and caspase activation and partially restored cell viability. However, (13)C MFA revealed that treatment with NAC did not normalize palmitate-induced metabolic alterations, indicating that neither elevated ROS nor downstream apoptotic events contributed to mitochondrial activation. To directly limit mitochondrial metabolism, the complex I inhibitor phenformin was added to cells treated with palmitate. Phenformin addition eliminated abnormal ROS accumulation, prevented the appearance of apoptotic markers, and normalized mitochondrial carbon flow. Further studies revealed that glutamine provided the primary fuel for elevated mitochondrial metabolism in the presence of palmitate, rather than fatty acid beta-oxidation, and that glutamine consumption could be reduced through co-treatment with phenformin but not NAC.
Our results indicate that ROS accumulation in palmitate-treated H4IIEC3 cells occurs downstream of altered mitochondrial oxidative metabolism, which is independent of beta-oxidation and precedes apoptosis initiation.
肝脂毒性的特征是活性氧(ROS)积累、线粒体功能障碍和细胞凋亡过度,但导致氧化损伤和细胞死亡的确切生化事件顺序尚不清楚。本研究的目的是阐明线粒体代谢在介导肝细胞脂毒性中的作用。
材料/方法:我们用游离脂肪酸联合抗氧化剂和线粒体抑制剂处理 H4IIEC3 大鼠肝癌细胞,以阻断向细胞凋亡进展的关键事件。然后,我们应用(13)C 代谢通量分析(MFA)来定量与这些处理相关的线粒体途径改变。
单独用棕榈酸处理可使耗氧率和大多数线粒体通量增加一倍。在培养基中补充抗氧化剂 N-乙酰半胱氨酸(NAC)可减少 ROS 积累和半胱天冬酶激活,并部分恢复细胞活力。然而,(13)C MFA 显示,用 NAC 处理并没有使棕榈酸诱导的代谢改变正常化,表明升高的 ROS 或下游凋亡事件都没有导致线粒体激活。为了直接限制线粒体代谢,将复合物 I 抑制剂二甲双胍添加到用棕榈酸处理的细胞中。二甲双胍的加入消除了异常的 ROS 积累,阻止了凋亡标志物的出现,并使线粒体碳流正常化。进一步的研究表明,在存在棕榈酸的情况下,谷氨酸提供了升高的线粒体代谢的主要燃料,而不是脂肪酸β氧化,并且可以通过与二甲双胍共同处理而不是 NAC 来减少谷氨酸消耗。
我们的结果表明,在棕榈酸处理的 H4IIEC3 细胞中 ROS 积累发生在改变的线粒体氧化代谢之后,与β氧化无关,并先于凋亡起始。